Fate Therapeutics
FATE
$3.80
Share price
-1.81%
Change (1 day)
-37.40%
Change (1 year)
Categories
Fate Therapeutics (FATE) - Total assets
Total assets on the balance sheet as of December 2023 : $0.50 B
According to Fate Therapeutics 's latest financial reports the company's total assets are $0.50 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Fate Therapeutics - Total assets on balance sheet (from 2012 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $0.50 B | -28.25% |
| 2022-12-31 | $0.70 B | -23.43% |
| 2021-12-31 | $0.92 B | 48.04% |
| 2020-12-31 | $0.62 B | 105.92% |
| 2019-12-31 | $0.30 B | 41.89% |
| 2018-12-31 | $0.21 B | 102.32% |
| 2017-12-31 | $0.10 B | 10.78% |
| 2016-12-31 | $95.04 M | 39.86% |
| 2015-12-31 | $67.95 M | 32.77% |
| 2014-12-31 | $51.18 M | -7.92% |
| 2013-12-31 | $55.58 M | 401.83% |
| 2012-12-31 | $11.07 M | 41.06% |
| 2011-12-31 | $7.85 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Becton Dickinson BDX | $52.27 B | 10,226.40% | 🇺🇸 USA |
 Sarepta Therapeutics
SRPT | $3.26 B | 544.90% | 🇺🇸 USA |
 PTC Therapeutics
PTCT | $1.89 B | 274.48% | 🇺🇸 USA |
 Neurocrine Biosciences
NBIX | $3.25 B | 542.29% | 🇺🇸 USA |
 Avidity Biosciences RNA | $0.62 B | 24.17% | 🇺🇸 USA |